Life Science REIT (LABS) Competitors GBX 44 -0.10 (-0.23%) As of 11:50 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsBuy This Stock LABS vs. THRL, IHR, MXF, AGR, PHP, PRSR, HWG, SHED, ESP, and MLIShould you be buying Life Science REIT stock or one of its competitors? The main competitors of Life Science REIT include Target Healthcare REIT (THRL), Impact Healthcare REIT (IHR), Medicx Fund (MXF), Assura (AGR), Primary Health Properties (PHP), Prs Reit (PRSR), Harworth Group (HWG), Urban Logistics REIT (SHED), Empiric Student Property (ESP), and Industrials REIT (MLI). These companies are all part of the "real estate" sector. Life Science REIT vs. Target Healthcare REIT Impact Healthcare REIT Medicx Fund Assura Primary Health Properties Prs Reit Harworth Group Urban Logistics REIT Empiric Student Property Industrials REIT Target Healthcare REIT (LON:THRL) and Life Science REIT (LON:LABS) are both small-cap real estate companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, community ranking, profitability, risk and dividends. Does the media refer more to THRL or LABS? In the previous week, Target Healthcare REIT and Target Healthcare REIT both had 2 articles in the media. Target Healthcare REIT's average media sentiment score of 0.52 beat Life Science REIT's score of -0.72 indicating that Target Healthcare REIT is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Target Healthcare REIT 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Life Science REIT 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Which has more volatility & risk, THRL or LABS? Target Healthcare REIT has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500. Comparatively, Life Science REIT has a beta of 0.08, indicating that its share price is 92% less volatile than the S&P 500. Do analysts prefer THRL or LABS? Life Science REIT has a consensus target price of GBX 46.50, suggesting a potential upside of 5.68%. Given Life Science REIT's stronger consensus rating and higher possible upside, analysts plainly believe Life Science REIT is more favorable than Target Healthcare REIT.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Target Healthcare REIT 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Life Science REIT 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Is THRL or LABS a better dividend stock? Target Healthcare REIT pays an annual dividend of GBX 6 per share and has a dividend yield of 6.1%. Life Science REIT pays an annual dividend of GBX 2 per share and has a dividend yield of 4.5%. Target Healthcare REIT pays out 50.3% of its earnings in the form of a dividend. Life Science REIT pays out -17.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Does the MarketBeat Community prefer THRL or LABS? Target Healthcare REIT received 89 more outperform votes than Life Science REIT when rated by MarketBeat users. However, 80.00% of users gave Life Science REIT an outperform vote while only 65.03% of users gave Target Healthcare REIT an outperform vote. CompanyUnderperformOutperformTarget Healthcare REITOutperform Votes9365.03% Underperform Votes5034.97% Life Science REITOutperform Votes480.00% Underperform Votes120.00% Is THRL or LABS more profitable? Target Healthcare REIT has a net margin of 104.99% compared to Life Science REIT's net margin of -198.99%. Target Healthcare REIT's return on equity of 10.78% beat Life Science REIT's return on equity.Company Net Margins Return on Equity Return on Assets Target Healthcare REIT104.99% 10.78% 3.86% Life Science REIT -198.99%-14.53%1.25% Which has better valuation and earnings, THRL or LABS? Target Healthcare REIT has higher revenue and earnings than Life Science REIT. Life Science REIT is trading at a lower price-to-earnings ratio than Target Healthcare REIT, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTarget Healthcare REIT£68.64M8.77£72.07M£11.938.24Life Science REIT£20.41M7.65-£40.62M-£11.28-3.90 Do insiders and institutionals believe in THRL or LABS? 69.4% of Target Healthcare REIT shares are held by institutional investors. Comparatively, 67.3% of Life Science REIT shares are held by institutional investors. 0.1% of Target Healthcare REIT shares are held by insiders. Comparatively, 7.0% of Life Science REIT shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryTarget Healthcare REIT beats Life Science REIT on 13 of the 19 factors compared between the two stocks. Remove Ads Get Life Science REIT News Delivered to You Automatically Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LABS vs. The Competition Export to ExcelMetricLife Science REITREIT IndustryReal Estate SectorLON ExchangeMarket Cap£156.21M£1.56B£1.64B£2.47BDividend Yield5.67%7.52%6.69%4.95%P/E Ratio-3.901.379.31129.48Price / Sales7.65540.421,331.79231,299.36Price / CashN/A49.2267.0627.98Price / Book0.581.361.194.45Net Income-£40.62M-£74.43M-£117.30M£5.80B7 Day Performance3.04%3.30%3.70%3.14%1 Month Performance1.15%0.58%-0.77%3.83%1 Year Performance14.29%12.19%3.65%102.57% Life Science REIT Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LABSLife Science REIT0.6164 of 5 starsGBX 44-0.2%GBX 46.50+5.7%+14.2%£156.21M£20.41M-3.90N/AEarnings ReportNews CoverageGap DownTHRLTarget Healthcare REITN/AGBX 89.20-2.7%N/A+26.9%£546.00M£68.64M7.48N/ANews CoverageIHRImpact Healthcare REITN/AN/AGBX 114+∞N/A£361.75M£53.51M793.64N/AMXFMedicx FundN/AN/AN/AN/A£0.00N/A0.00N/AHigh Trading VolumeAGRAssura1.2414 of 5 starsGBX 47.44+5.0%GBX 51+7.5%+19.3%£1.55B£188.76M-45.3584Gap UpHigh Trading VolumePHPPrimary Health Properties1.0634 of 5 starsGBX 92.70-1.8%GBX 107.50+16.0%+10.7%£1.24B£178.59M-144.7058PRSRPrs Reit2.485 of 5 starsGBX 107.20-2.0%GBX 120+11.9%+49.9%£586.71M£58.11M6.262High Trading VolumeHWGHarworth GroupN/AGBX 166+0.3%N/A+34.0%£546.51M£97.22M10.94120News CoverageSHEDUrban Logistics REIT0.8795 of 5 starsGBX 115.60-3.0%GBX 142+22.8%+33.3%£536.57M£58.96M22.01N/AESPEmpiric Student PropertyN/AGBX 80.60-3.0%N/A+1.2%£533.90M£89.58M9.05150MLIIndustrials REITN/AN/AN/AN/A£494.79M£50.19M1,050.005,140 Remove Ads Related Companies and Tools Related Companies Target Healthcare REIT Alternatives Impact Healthcare REIT Alternatives Medicx Fund Alternatives Assura Alternatives Primary Health Properties Alternatives Prs Reit Alternatives Harworth Group Alternatives Urban Logistics REIT Alternatives Empiric Student Property Alternatives Industrials REIT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:LABS) was last updated on 4/17/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Life Science REIT plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Life Science REIT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LABS Stock Free LABS Stock Alerts